Compile Data Set for Download or QSAR
maximum 50k data
Found 589 with Last Name = 'ondeyka' and Initial = 'd'
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282276(CHEMBL304947 | Pentanoic acid {2-butyl-3-[2'-(3-cy...)
Affinity DataIC50:  0.100nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282274(4'-(2-Ethyl-5,7-dimethyl-imidazo[4,5-b]pyridin-3-y...)
Affinity DataIC50:  0.100nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282277(CHEMBL306407 | Imidazo[4,5-b]pyridine derivative)
Affinity DataIC50:  0.110nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282281(CHEMBL68618 | Pentanoic acid {2-butyl-3-[2'-(3-cyc...)
Affinity DataIC50:  0.120nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123235(US8742110, 3-20)
Affinity DataIC50:  0.129nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123247(US8742110, 4-11)
Affinity DataIC50:  0.152nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123253(US8742110, 4-17)
Affinity DataIC50:  0.165nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123270(US8742110, 5-6)
Affinity DataIC50:  0.172nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123248(US8742110, 4-12)
Affinity DataIC50:  0.188nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-1/Type-2 angiotensin II receptor(Homo sapiens (Human))
Exploratory Chemistry Merck Sharp And Dohme Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50229575(CHEMBL2369937)
Affinity DataIC50:  0.200nMAssay Description:Binding affinity towards Angiotensin receptor from rabbit aortaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123300(US8742110, 6-18)
Affinity DataIC50:  0.225nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123254(US8742110, 4-18)
Affinity DataIC50:  0.228nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123271(US8742110, 5-7)
Affinity DataIC50:  0.233nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123255(US8742110, 4-19)
Affinity DataIC50:  0.243nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(RAT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282279(CHEMBL304946 | N-{3-[2'-(3-Cyclopentyl-propionylsu...)
Affinity DataIC50:  0.25nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from AT2 receptor in rat midbrain m...More data for this Ligand-Target Pair
In DepthDetails Article
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282279(CHEMBL304946 | N-{3-[2'-(3-Cyclopentyl-propionylsu...)
Affinity DataIC50:  0.260nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123296(US8742110, 6-14)
Affinity DataIC50:  0.260nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282286(CHEMBL71388 | Imidazo[4,5-b]pyridine derivative)
Affinity DataIC50:  0.270nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123252(US8742110, 4-16)
Affinity DataIC50:  0.272nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-1/Type-2 angiotensin II receptor(Homo sapiens (Human))
Exploratory Chemistry Merck Sharp And Dohme Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50229912(CHEMBL315104)
Affinity DataIC50:  0.300nMAssay Description:Binding affinity towards Angiotensin receptor from rabbit aortaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetType-1/Type-2 angiotensin II receptor(Homo sapiens (Human))
Exploratory Chemistry Merck Sharp And Dohme Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50009718(2-Ethyl-5,7-dimethyl-3-[2'-(1H-tetrazol-5-yl)-biph...)
Affinity DataIC50:  0.300nMAssay Description:Binding affinity towards Angiotensin receptor from rabbit aortaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50009718(2-Ethyl-5,7-dimethyl-3-[2'-(1H-tetrazol-5-yl)-biph...)
Affinity DataIC50:  0.300nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetType-2 angiotensin II receptor(RAT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282276(CHEMBL304947 | Pentanoic acid {2-butyl-3-[2'-(3-cy...)
Affinity DataIC50:  0.310nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from AT2 receptor in rat midbrain m...More data for this Ligand-Target Pair
In DepthDetails Article
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123277(US8742110, 5-13)
Affinity DataIC50:  0.317nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123227(US8742110, 3-12)
Affinity DataIC50:  0.323nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50049185(4'-[2-Butyl-6-(3-isopropyl-3-methyl-ureido)-4-oxo-...)
Affinity DataIC50:  0.330nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123306(US8742110, 6-24)
Affinity DataIC50:  0.342nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123234(US8742110, 3-19)
Affinity DataIC50:  0.359nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282283(CHEMBL67801 | Pentanoic acid [2-butyl-3-(2'-hexano...)
Affinity DataIC50:  0.370nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123264(US8742110, 4-28)
Affinity DataIC50:  0.395nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123257(US8742110, 4-21)
Affinity DataIC50:  0.397nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123250(US8742110, 4-14)
Affinity DataIC50:  0.407nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123243(US8742110, 4-7)
Affinity DataIC50:  0.409nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123179(US8742110, 1-28)
Affinity DataIC50:  0.421nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123272(US8742110, 5-8)
Affinity DataIC50:  0.424nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123236(US8742110, 3-21)
Affinity DataIC50:  0.437nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123245(US8742110, 4-9)
Affinity DataIC50:  0.439nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(RAT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282281(CHEMBL68618 | Pentanoic acid {2-butyl-3-[2'-(3-cyc...)
Affinity DataIC50:  0.450nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from AT2 receptor in rat midbrain m...More data for this Ligand-Target Pair
In DepthDetails Article
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123258(US8742110, 4-22)
Affinity DataIC50:  0.468nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(RAT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282277(CHEMBL306407 | Imidazo[4,5-b]pyridine derivative)
Affinity DataIC50:  0.470nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from AT2 receptor in rat midbrain m...More data for this Ligand-Target Pair
In DepthDetails Article
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123244(US8742110, 4-8)
Affinity DataIC50:  0.474nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123239(US8742110, 4-3)
Affinity DataIC50:  0.490nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282282(CHEMBL71253 | Pentanoic acid benzyl-{2-butyl-5-met...)
Affinity DataIC50:  0.5nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetType-1/Type-2 angiotensin II receptor(Homo sapiens (Human))
Exploratory Chemistry Merck Sharp And Dohme Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50229914(CHEMBL98907)
Affinity DataIC50:  0.5nMAssay Description:Binding affinity towards Angiotensin receptor from rabbit aortaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123240(US8742110, 4-4)
Affinity DataIC50:  0.502nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-1 angiotensin II receptor(RABBIT)
TBA

Curated by ChEMBL
LigandPNGBDBM50282273(CHEMBL67921 | Imidazo[4,5-b]pyridine derivative)
Affinity DataIC50:  0.510nMAssay Description:In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type ...More data for this Ligand-Target Pair
In DepthDetails Article
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123242(US8742110, 4-6)
Affinity DataIC50:  0.546nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123307(US8742110, 6-25)
Affinity DataIC50:  0.550nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123241(US8742110, 4-5)
Affinity DataIC50:  0.556nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123180(US8742110, 1-29)
Affinity DataIC50:  0.582nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 589 total ) | Next | Last >>
Jump to: